Mối liên hệ giữa chức năng phổi với các biomarker huyết thanh và độ đầy đủ của liệu pháp lọc máu ở bệnh nhân thực hiện lọc màng bụng

Turcios NL. Pulmonary complications of renal disorders. Paediatr Respir Rev. 2012;13:44–9. Engstrom G, Lind P, Hedblad B, Wollmer P, Stavenow L, Janzon L, Lindgarde F. Lung function and cardiovascular risk—relationship with inflammation-sensitive plasma proteins. Circulation. 2002;106:2555–60. Razeghi E, Parkhideh S, Ahmadi F, Khashayar P. Serum CRP levels in pre-dialysis patients. Ren Fail. 2008;30:193–8. Balasubramanian VP, Varkey B. Chronic obstructive pulmonary disease: effects beyond the lungs. Curr Opin Pulm Med. 2006;12:106–12. Sin DD, Man SFP. Systemic inflammation and mortality in chronic obstructive pulmonary disease. Can J Physiol Pharmacol. 2007;85:141–7. II. NKF-K/DOQI Clinical practice guidelines for peritoneal dialysis adequacy: update 2000. Am J Kidney Dis. 2001; 37: S65–S136. Bergstrom J, Furst P, Alvestrand A, Lindholm B. Protein and energy-intake, nitrogen-balance and nitrogen losses in patients treated with continuous ambulatory peritoneal-dialysis. Kidney Int. 1993;44:1048–57. Bergstrom J, Heimburger O, Lindholm B. Calculation of the protein equivalent of total nitrogen appearance from urea appearance. Which formulas should be used? Perit Dial Int. 1998;18:467–73. Tang X, Wang Y, Yang L, Yuan Y. The influence of peritoneal dialysis on the pulmonary function of patients with end-stage renal disease. J West China U Med Sci. 2002;33:123–46. Hancox RJ, Poulton R, Greene JM, Filsell S, McLachlan CR, Rasmussen F, Taylor DR, Williams MJ, Williamson A, Sears MR. Systemic inflammation and lung function in young adults. Thorax. 2007;62:1064–8. Bolton CE, Schumacher W, Cockcroft JR, Timpson NJ, Smith GD, Gallacher J, Rumley A, Lowe GD, Ebrahim S, Shale DJ, Ben-Shlomo Y. The CRP genotype, serum levels and lung function in men: the caerphilly prospective study. Clin Sci. 2011;120:347–55. Jiang R, Burke GL, Enright PL, Newman AB, Margolis HG, Cushman M, Tracy RP, Wang Y, Kronmal RA, Barr RG. Inflammatory markers and longitudinal lung function decline in the elderly. Am J Epidemiol. 2008;168:602–10. Shaaban R, Kony S, Driss F, Leynaert B, Soussan D, Pin I, Neukirch F, Zureik M. Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study. Resp Med. 2006;100:2112–20. Olafsdottir IS, Gislason T, Gudnason V, Benediktsdottir B, Olafsson I, Aspelund T, Thjodleifsson B, Janson C. CRP is associated with lung function decline in men but not women: a prospective study. Resp Med. 2013;107:91–7. Higashimoto Y, Iwata T, Okada M, Hiroaki S, Fukuda K, Tohda Y. Serum biomarkers as predictors of lung function decline in chronic obstructive pulmonary disease. Resp Med. 2009;103:1231–8. Rasmussen F, Mikkelsen D, Hancox RJ, Lambrechtsen J, Nybo M, Hansen HS, Siersted HC. High-sensitive C-reactive protein is associated with reduced lung function in young adults. Eur Respir J. 2009;33:382–8. Alexeeff SE, Litonjua AA, Sparrow D, Vokonas PS, Schwartz J. Statin use reduces decline in lung function—VA normative aging study. Am J Respir Crit Care Med. 2007;176:742–7. Kuhlmann A, Olafsdottir IS, Lind L, Sundstrom J, Janson C. Association of biomarkers of inflammation and cell adhesion with lung function in the elderly: a population-based study. BMC Geriatr. 2013;13. Thomsen M, Ingebrigtsen TS, Marott JL, Dahl M, Lange P, Vestbo J, Nordestgaard BG. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. Jama J AM Med Assoc. 2013;309:2353–61. Ahmadi-Abhari S, Kaptoge S, Luben RN, Wareham NJ, Khaw K-T. Longitudinal association of C-reactive protein and lung function over 13 Years The EPIC-norfolk study. Am J Epidemiol. 2014;179:48–56. Feng J, Ni SS, Zhou J. Research of C-reactive protein and endothelial cell activation factor change in chronic obstructive pulmonary disease. Chin J Nauti Med Hyper. 2009;16:284–6. Liu WJ, Liang R. Correlation study of detection of serumhs-CRP, TNF-α and IL-6 to lung function and life quality in COPD patients. J Clin Pulm Med. 2013;18:616–7. Wynants M, Quarck R, Ronisz A, Alfaro-Moreno E, Van Raemdonck D, Meyns B, Delcroix M. Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2012;40:886–94. Faubel S. Pulmonary complications after acute kidney injury. Adv Chronic Kidney Dis. 2008;15:284–96. Feng C, Wang YJ, Tang H. Effects of hemodialysis on pulmonary function in patients with uremia. Med J West China. 2009;21:390–1. Bloembergen WE. Cardiac disease in chronic uremia: epidemiology. Adv Ren Replace Ther. 1997;4:185–93. Rubin LJ. Current concepts—primary pulmonary hypertension. N Engl J Med. 1997;336:111–7. Tarrass F, Benjelloun M, Medkouri G, Hachim K, Benghanem MG, Ramdani B. Doppler echocardiograph evaluation of pulmonary hypertension in patients undergoing hemodialysis. Hemodial Int. 2006;10:356–9. Giuseppe E, Rocco T, Vincenzo P, Claudia T, Maurizio G, Giovanni GB, Carmine Z. Pulmonary congestion and physical functioning in peritoneal dialysis patients. Perit Dialysis Int. 2012;32:531–53630. Tao Y, Wang YJ, Yang SM. Measurement of respiratory excitability and respiratory muscle strength in uremic patients. China Pratic Med. 2001;3:4–6. Souza dos Santos Simon MI, Drehmer M, de Abreu e Silva FA, Hoffmann A, Druck Ricachinewsky C, de Fonseca Andrade Procianoy E, Scattolin I, Saldanha Menna Barreto S. Association of nutritional status, plasma, albumin levels and pulmonary function in cystic fibrosis. Nutr Hosp. 2011; 26: 1322–27. Cueto-Manzano AM, Espinosa A, Herna´ndez A, Correa-Rotter R. Peritoneal transport kinetics correlate with serum albumin but not with the overall nutritional status in CAPD patients. Am J Kidney Dis. 1997;30:229–36. Shioya M, Yoshida T, Kasai K, Furuya R, Kato A, et al. Inflammatory factors for hypoalbuminemia in Japanese peritoneal dialysis patients. Nephrology. 2013;l8:539–544.